Increasing use of new prescription drugs: A case study

Health Affairs

Volumn 19, Issue 4, 2000, Pages 165-170

  Foote, Sandra M ^a   Etheredge, Lynn ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b HIRP from Chevy Chase   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; DRUG COST; DRUG UTILIZATION; ECONOMICS; FORECASTING; HEALTH INSURANCE; HEALTH SERVICE; HEALTH SERVICES RESEARCH; HUMAN; INSURANCE; MASS COMMUNICATION; MEDICARE; PRESCRIPTION; UNITED STATES;

ANTIDEPRESSIVE AGENTS; DIFFUSION OF INNOVATION; DRUG COSTS; DRUG UTILIZATION; FORECASTING; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MEDICARE; ORGANIZATIONAL CASE STUDIES; PRESCRIPTIONS, DRUG; UNITED STATES;

EID: 0034223432     PISSN: 02782715     EISSN: None     Source Type: Journal    
DOI: 10.1377/hlthaff.19.4.165     Document Type: Article

References (22)

1. V.R. Fuchs, "Health Care for the Elderly: How Much? Who Will Pay for It?" Health Affairs (Jan/Feb 1999): 11-21.
2. F. Teitelbaum et al., 1998 Express Scripts Drug Trend Report (St. Louis: Express Scripts, Inc., June 1999), 20.
3. Factors Affecting the Growth of Prescription Drug Expenditures (Washington: National Institute for Health Care Management Research and Educational Foundation, 9 July 1999), 7.
4. U.S. Department of Health and Human Services, Mental Health: A Report of the Surgeon General (Rockville, Md.: DHHS, 1999), 252, 258, 263, 264.
5. Important patents for Prozac expire in 2001 and 2003. Generic equivalents may then drive down prices on all antidepressants until improved brand-name antidepressants are introduced.
6. IMS Health data presented by Thomas Croghan, Health Insurance Reform Project meeting. Washington, D.C., 2 November 1999.
7. C.J. Murray and A.D. Lopez, eds., The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020 (Cambridge, Mass.: Harvard School of Public Health, for the World Health Organization and the World Bank, 1996), 375.
8. National Disease and Therapeutic Index data collected by IMS Health, in D.L. Loosbrock et al., "Appropriate Use of Selective Serotonin Reuptake Inhibitors: Diagnosis and Dose at Time of Initial Use" (Paper presented at the Annual Meeting of the American Psychiatric Association, Washington, D.C., 19 May 1999).
9. K.B. Wells et al., "Impact of Disseminating Quality Improvement Programs for Depression in Managed Primary Care," Journal of the American Medical Association (12 January 2000): 212.
10. "Prescription Drug Ad Spending in U.S. Exceeds θ 1.2 Billion through November 1998," Medical Benefits (15 March 1999): 6.
11. R. Emigh, "Trends in Pharmaceutical Utilization in the U.S." (Presentation at the National Congress on Pharmaceuticals in Medicine, Arlington, Virginia, 9 December 1999).
12. Factors Affecting the Growth of Prescription Drug Expenditures, 14, 15.
13. See Note 6.
14. Wells et al., "Impact of Disseminating Quality Improvement Programs."
15. J.W. Williams et al., "Primary Care Physicians' Approach to Depressive Disorders," Archives of Family Medicine (Jan/Feb 1999): 62, 63. See also K. Way et al., "Antidepressant Utilization Patterns in a National Managed Care Organization," Drug Benefit Trends (11 September 1999): 6.
16. J.W. Williams et al., "Primary Care Physicians' Approach to Depressive Disorders," Archives of Family Medicine (Jan/Feb 1999): 62, 63. See also K. Way et al., "Antidepressant Utilization Patterns in a National Managed Care Organization," Drug Benefit Trends (11 September 1999): 6.
17. For National Health Expenditure Survey data, see www.hcfa.gov/stats/NHE-Proj/proj1998/ tables (12 December 1999).
18. Teitelbaum et al., 1998 Express Scripts Drug Trend Refort, 33, 35.
19. D. Mechanic, "Muddling Through Elegantly: Finding the Proper Balance in Rationing," Health Affairs (Sep/Oct 1997): 83. See also G. Calabresi and P. Bobbit, Tragic Choices (New York: W.W. Norton, 1978), 17-26, 195-199.
20. D. Mechanic, "Muddling Through Elegantly: Finding the Proper Balance in Rationing," Health Affairs (Sep/Oct 1997): 83. See also G. Calabresi and P. Bobbit, Tragic Choices (New York: W.W. Norton, 1978), 17-26, 195-199.
21. Pharmaceutical Research and Manufacturers of America, Pharmaceutical Industry Profile, 1999, available online at www.phrma.org/publications/ industry/profile99/chap2.html#growth (2 December 1999).
22. "AHCPR Launches Research Program to Improve the Safe and Effective Use of Medical Products" (Press release, available online at www.ahcpr.gov/news/press/pr1999/medpropr.htm, 29 September 1999).